Consensus statement on prevention of disability

Leprosy Review

Volumn 77, Issue 4, 2006, Pages 387-395

  Augustine, Valsa ^a   Brantus, Pierre ^a   Cross, Hugh ^a   Ebenso, Jannine ^a   Goucheng, Zhang ^a   Hisch, Ernst ^a   Rao, Ranganadh ^a   Saunderson, Paul ^a   Smith, Cairns ^a   Soutar, Doug ^a   Van Brakel, Wim ^a   Lockwood, Diana ^a   Norman, Gift ^a   Pannikar, Vijay ^a  

^a NONE

Author keywords

[No Author keywords available]

Indexed keywords

CLOFAZIMINE; STEROID;

CONFERENCE PAPER; CONSENSUS DEVELOPMENT; DISABILITY; HEALTH CARE ORGANIZATION; HEALTH CARE PERSONNEL; HEALTH CARE PRACTICE; HUMAN; LEPROSY; NEURITIS; PREVENTIVE MEDICINE; SELF CARE;

EID: 33947270825     PISSN: 03057518     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Conference Paper

References (25)

1. Global Strategy for Further Reducing the Leprosy Burden and Sustaining Leprosy Control Activities (Plan period: 2006-2010), WHO/CDS/CPE/CEE/ 2005.53 WHO, Geneva 2005.
2. ILEP Learning Guide One: How to diagnose and treat leprosy. London, 2001.
3. ILEP Learning Guide Two: How to recognize and manage leprosy reactions. London, 2002.
4. ILEP Learning Guide Four: How to prevent disability in leprosy. London, 2006.
5. Operational Guidelines, SEA/GLP/2006.2 WHO, New Delhi 2006.
6. Prevention of blindness in leprosy (2nd edition). Courtright and Lewallen, 2006.
7. Wound care for people affected by leprosy: a guide for low resource situations. Hugh Cross.
8. Croft RP et al. A clinical prediction rule for nerve-function impairment in leprosy patients. Lancet, 2000; 355: 1603-1606.
9. Croft RP, Nicholls PG, Richardus JH, Smith WC. The treatment of acute nerve function impairment in leprosy: results from a prospective cohort study in Bangladesh. Lepr Rev, 2000; 71: 154-168.
10. Richardus JH, Nicholls PG, Croft RP et al. Incidence of acute nerve function impairment and reactions in leprosy: a prospective cohort analysis after 5 years of follow-up. Int J Epidemiol, 2004; 33: 337-343.
11. Rao PS, Sugamaran DS, Richard J, Smith WC. Multi-centre, double blind, randomized trial of three steroid regimens in the treatment of type-1 reactions in leprosy. Lepr Rev, 2006; 77: 25-33.
12. Saunderson P, Gebre S, Desta K, Byass P, Lockwood DN. The pattern of leprosy-related neuropathy in the AMFES patients in Ethiopia: definitions, incidence, risk factors and outcome. Lepr Rev, 2000; 71: 285-308.
13. van Brakel WH, Nicholls PG, Das L et al. The INFIR Cohort Study: investigating prediction, detection and pathogenesis of neuropathy and reactions in leprosy. Methods and baseline results of a cohort of multibacillary leprosy patients in north India. Lepr Rev, 2005; 76: 14-34.
14. Benbow C, Tamiru T. The experience of self-care groups with people affected by leprosy: ALERT. Ethiopia. Lepr Rev, 2001; 72: 311-321.
15. Cross H, Choudhary R. STEP: an intervention to address the issue of stigma related to leprosy in Southern Nepal. Lepr Rev, 2005; 76: 316-324.
16. Smith WC, Zhang G, Zheng T et al. Prevention of impairment in leprosy; results from a collaborative project in China. Int J Lepr, 1995; 63: 507-517.
17. WHO. Innovative Care for Chronic Conditions (ICCC) Framework. http://www.who.int/chronic_conditions/framework/en/ 2006.
18. Birke J, Foto F, Deepak S, Watson J. Measurement of pressure walking in footwear used in leprosy. Lep Rev, 1994; 65: 262-271.
19. Brand P. Insensitive feet. a practical handbook on foot problems in leprosy. TLMI.
20. Praet S, Louwerens J. The influence of shoe designs on plantar presses in neuropathic feet. Diabetes Care, 2003; 26: 441-445.
21. Seboka G, Saunderson P. Cost effective footwear for leprosy control programmes: a study in rural Ethiopia. Lepr Rev, 1996; 67: 208-216.
22. Reed NK, van Brakel WH, Reed DS. Progress of impairment scores following commencement of chemotherapy in multibacillary leprosy patients. Int J Lepr, 1997; 65: 328-336.
23. Nicholls PG et al. Risk factors for participation restriction in leprosy and development of a screening tool to identify individuals at risk. Lepr Rev, 2005; 76: 305-315.
24. The SALSA Collaborative Study Group. The development of a short questionnaire for Screening of Activity Limitation and Safety Awareness (SALSA) in clients affected by leprosy or diabetes. Disability and Rehabilitation (in press).
25. van Brakel WH, Anderson AM, Mutatkar RK et al. The participation scale: measuring a key concept in public health. Disability and Rehabilitation, 2006; 28: 193-203.